Showing results (121-130 of 460) with videos related to
Sort By:
Pageof 46
Lymphology|February 9, 1999
Levels of eicosanoids (6-oxo-PGF1 alpha and 8-epi-PGF2 alpha) in human and porcine lymphatics and lymphA Oguogho, J Kaliman, H SinzingerKlinische Wochenschrift|September 1, 1988
[Prevalence of plasma factor deficiency in the Vienna population. Results of a screening study of 1,300 adults]H Sinzinger, J Flores, F RauschaThe Journal of International Medical Research|January 1, 1988
Platelet deposition on human atherosclerotic lesions is decreased by low-dose aspirin in combination with dipyridamoleH Sinzinger, J O'Grady, P FitschaEuropean Journal of Nuclear Medicine|September 2, 1998
Adsorption of technetium-99m tetrofosmin and technetium-99m furifosmin on plastic syringesR Bartosch, S Granegger, H SinzingerBritish Journal of Experimental Pathology|February 1, 1979
Prostacyclin activity in rat kidney stimulated by angiotensin IIK Silberbauer, H Sinzinger, M WinterLymphology|October 6, 1997
Isoprostane 8-epi-prostaglandin F2 alpha is a potent contractor of human peripheral lymphaticsH Sinzinger, A Oguogho, J KalimanProstaglandins|June 1, 1987
Prostaglandin I2 during radiolabelling improves recovery, but does not change platelet half-life and platelet uptake over active human lesion sitesH Sinzinger, P Fitscha, J KalimanAngiology|February 1, 1986
Platelet half-life, plasma thromboxane B2 and circulating endothelial-cells in peripheral vascular diseaseH Sinzinger, P Fitscha, B A PeskarProstaglandins & Other Lipid Mediators|July 14, 1998
Do E-series prostaglandins and their metabolites influence oxidation of native and glycated low-density lipoproteins?G Sobal, J E Menzel, H SinzingerBiochemical Pharmacology|February 15, 2001
Calcium antagonists as inhibitors of in vitro low density lipoprotein oxidation and glycationG Sobal, E J Menzel, H SinzingerPageof 46